Arcutis Biotherapeutics, Inc. (ARQT)
25.05
-0.09
(-0.36%)
USD |
NASDAQ |
Aug 27, 14:33
Arcutis Biotherapeutics Total Return Level : 25.14 for Aug. 26, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| August 26, 2026 | 25.14 |
| August 25, 2026 | 24.86 |
| August 24, 2026 | 24.78 |
| August 21, 2026 | 25.08 |
| August 20, 2026 | 25.35 |
| August 19, 2026 | 26.46 |
| August 18, 2026 | 26.54 |
| August 17, 2026 | 25.61 |
| August 14, 2026 | 26.19 |
| August 13, 2026 | 25.83 |
| August 12, 2026 | 26.28 |
| August 11, 2026 | 26.23 |
| August 10, 2026 | 25.92 |
| August 07, 2026 | 25.29 |
| August 06, 2026 | 26.43 |
| August 05, 2026 | 27.10 |
| August 04, 2026 | 26.03 |
| August 03, 2026 | 25.94 |
| July 31, 2026 | 26.86 |
| July 30, 2026 | 27.99 |
| July 29, 2026 | 27.86 |
| July 28, 2026 | 28.42 |
| July 27, 2026 | 27.84 |
| July 24, 2026 | 27.35 |
| July 23, 2026 | 27.33 |
| Date | Value |
|---|---|
| July 22, 2026 | 27.90 |
| July 21, 2026 | 28.26 |
| July 20, 2026 | 27.53 |
| July 17, 2026 | 28.49 |
| July 16, 2026 | 27.74 |
| July 15, 2026 | 27.78 |
| July 14, 2026 | 26.81 |
| July 13, 2026 | 27.12 |
| July 10, 2026 | 27.74 |
| July 09, 2026 | 28.78 |
| July 08, 2026 | 28.50 |
| July 07, 2026 | 27.67 |
| July 06, 2026 | 26.07 |
| July 02, 2026 | 25.81 |
| July 01, 2026 | 25.84 |
| June 30, 2026 | 26.22 |
| June 29, 2026 | 26.76 |
| June 26, 2026 | 27.00 |
| June 25, 2026 | 26.69 |
| June 24, 2026 | 27.37 |
| June 23, 2026 | 26.27 |
| June 22, 2026 | 26.66 |
| June 18, 2026 | 26.21 |
| June 17, 2026 | 26.22 |
| June 16, 2026 | 25.67 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| ACADIA Pharmaceuticals, Inc. | 29.58 |
| Insmed, Inc. | 124.39 |
| Emergent BioSolutions, Inc. | 5.97 |
| Exelixis, Inc. | 56.10 |
| Vertex Pharmaceuticals, Inc. | 547.29 |